nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—Erectile dysfunction—Lovastatin—atherosclerosis	0.0127	0.018	CcSEcCtD
Propantheline—Erectile dysfunction—Ezetimibe—atherosclerosis	0.0125	0.0176	CcSEcCtD
Propantheline—Abdominal distension—Niacin—atherosclerosis	0.0119	0.0169	CcSEcCtD
Propantheline—Erectile dysfunction—Simvastatin—atherosclerosis	0.0119	0.0168	CcSEcCtD
Propantheline—Dysphagia—Niacin—atherosclerosis	0.0118	0.0167	CcSEcCtD
Propantheline—Abdominal distension—Pravastatin—atherosclerosis	0.0117	0.0166	CcSEcCtD
Propantheline—Erectile dysfunction—Niacin—atherosclerosis	0.0109	0.0154	CcSEcCtD
Propantheline—Erectile dysfunction—Pravastatin—atherosclerosis	0.0107	0.0152	CcSEcCtD
Propantheline—Flushing—Lovastatin—atherosclerosis	0.0102	0.0145	CcSEcCtD
Propantheline—Flushing—Ezetimibe—atherosclerosis	0.01	0.0142	CcSEcCtD
Propantheline—Flushing—Simvastatin—atherosclerosis	0.00958	0.0136	CcSEcCtD
Propantheline—Confusional state—Rosuvastatin—atherosclerosis	0.00933	0.0132	CcSEcCtD
Propantheline—Vision blurred—Lovastatin—atherosclerosis	0.00906	0.0128	CcSEcCtD
Propantheline—Flushing—Niacin—atherosclerosis	0.0088	0.0124	CcSEcCtD
Propantheline—Flushing—Pravastatin—atherosclerosis	0.00866	0.0123	CcSEcCtD
Propantheline—Vision blurred—Simvastatin—atherosclerosis	0.00847	0.012	CcSEcCtD
Propantheline—Insomnia—Rosuvastatin—atherosclerosis	0.00837	0.0118	CcSEcCtD
Propantheline—Palpitations—Ezetimibe—atherosclerosis	0.00833	0.0118	CcSEcCtD
Propantheline—Tension—Niacin—atherosclerosis	0.0081	0.0115	CcSEcCtD
Propantheline—Nervousness—Niacin—atherosclerosis	0.00802	0.0113	CcSEcCtD
Propantheline—Dry mouth—Lovastatin—atherosclerosis	0.008	0.0113	CcSEcCtD
Propantheline—Tension—Pravastatin—atherosclerosis	0.00798	0.0113	CcSEcCtD
Propantheline—Constipation—Rosuvastatin—atherosclerosis	0.00791	0.0112	CcSEcCtD
Propantheline—Confusional state—Lovastatin—atherosclerosis	0.00791	0.0112	CcSEcCtD
Propantheline—Nervousness—Pravastatin—atherosclerosis	0.00789	0.0112	CcSEcCtD
Propantheline—Dry mouth—Ezetimibe—atherosclerosis	0.00785	0.0111	CcSEcCtD
Propantheline—Anaphylactic shock—Lovastatin—atherosclerosis	0.00784	0.0111	CcSEcCtD
Propantheline—Vision blurred—Niacin—atherosclerosis	0.00778	0.011	CcSEcCtD
Propantheline—Confusional state—Ezetimibe—atherosclerosis	0.00776	0.011	CcSEcCtD
Propantheline—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00769	0.0109	CcSEcCtD
Propantheline—Vision blurred—Pravastatin—atherosclerosis	0.00766	0.0108	CcSEcCtD
Propantheline—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00763	0.0108	CcSEcCtD
Propantheline—Confusional state—Simvastatin—atherosclerosis	0.0074	0.0105	CcSEcCtD
Propantheline—Urticaria—Rosuvastatin—atherosclerosis	0.00735	0.0104	CcSEcCtD
Propantheline—Anaphylactic shock—Simvastatin—atherosclerosis	0.00734	0.0104	CcSEcCtD
Propantheline—Palpitations—Niacin—atherosclerosis	0.00729	0.0103	CcSEcCtD
Propantheline—Insomnia—Lovastatin—atherosclerosis	0.00709	0.01	CcSEcCtD
Propantheline—Insomnia—Ezetimibe—atherosclerosis	0.00696	0.00984	CcSEcCtD
Propantheline—Dry mouth—Niacin—atherosclerosis	0.00687	0.00972	CcSEcCtD
Propantheline—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00682	0.00964	CcSEcCtD
Propantheline—Anaphylactic shock—Niacin—atherosclerosis	0.00674	0.00952	CcSEcCtD
Propantheline—Constipation—Lovastatin—atherosclerosis	0.00671	0.00948	CcSEcCtD
Propantheline—Confusional state—Pravastatin—atherosclerosis	0.00669	0.00946	CcSEcCtD
Propantheline—Asthenia—Rosuvastatin—atherosclerosis	0.00664	0.00939	CcSEcCtD
Propantheline—Insomnia—Simvastatin—atherosclerosis	0.00664	0.00938	CcSEcCtD
Propantheline—Anaphylactic shock—Pravastatin—atherosclerosis	0.00663	0.00938	CcSEcCtD
Propantheline—Constipation—Ezetimibe—atherosclerosis	0.00658	0.0093	CcSEcCtD
Propantheline—Tachycardia—Niacin—atherosclerosis	0.00657	0.0093	CcSEcCtD
Propantheline—Feeling abnormal—Lovastatin—atherosclerosis	0.00646	0.00914	CcSEcCtD
Propantheline—Feeling abnormal—Ezetimibe—atherosclerosis	0.00634	0.00896	CcSEcCtD
Propantheline—Constipation—Simvastatin—atherosclerosis	0.00627	0.00887	CcSEcCtD
Propantheline—Urticaria—Lovastatin—atherosclerosis	0.00623	0.00881	CcSEcCtD
Propantheline—Dizziness—Rosuvastatin—atherosclerosis	0.00612	0.00865	CcSEcCtD
Propantheline—Urticaria—Ezetimibe—atherosclerosis	0.00611	0.00864	CcSEcCtD
Propantheline—Insomnia—Niacin—atherosclerosis	0.00609	0.00861	CcSEcCtD
Propantheline—Feeling abnormal—Simvastatin—atherosclerosis	0.00605	0.00855	CcSEcCtD
Propantheline—Insomnia—Pravastatin—atherosclerosis	0.006	0.00848	CcSEcCtD
Propantheline—Somnolence—Niacin—atherosclerosis	0.00599	0.00847	CcSEcCtD
Propantheline—Rash—Rosuvastatin—atherosclerosis	0.00584	0.00825	CcSEcCtD
Propantheline—Dermatitis—Rosuvastatin—atherosclerosis	0.00583	0.00824	CcSEcCtD
Propantheline—Urticaria—Simvastatin—atherosclerosis	0.00583	0.00824	CcSEcCtD
Propantheline—Headache—Rosuvastatin—atherosclerosis	0.0058	0.0082	CcSEcCtD
Propantheline—Hypersensitivity—Lovastatin—atherosclerosis	0.00578	0.00817	CcSEcCtD
Propantheline—Constipation—Pravastatin—atherosclerosis	0.00567	0.00802	CcSEcCtD
Propantheline—Hypersensitivity—Ezetimibe—atherosclerosis	0.00567	0.00801	CcSEcCtD
Propantheline—Asthenia—Lovastatin—atherosclerosis	0.00563	0.00796	CcSEcCtD
Propantheline—Asthenia—Ezetimibe—atherosclerosis	0.00552	0.0078	CcSEcCtD
Propantheline—Nausea—Rosuvastatin—atherosclerosis	0.0055	0.00777	CcSEcCtD
Propantheline—Feeling abnormal—Pravastatin—atherosclerosis	0.00547	0.00773	CcSEcCtD
Propantheline—Hypersensitivity—Simvastatin—atherosclerosis	0.00541	0.00764	CcSEcCtD
Propantheline—Urticaria—Niacin—atherosclerosis	0.00535	0.00757	CcSEcCtD
Propantheline—Urticaria—Pravastatin—atherosclerosis	0.00527	0.00745	CcSEcCtD
Propantheline—Asthenia—Simvastatin—atherosclerosis	0.00526	0.00744	CcSEcCtD
Propantheline—Dizziness—Lovastatin—atherosclerosis	0.00519	0.00733	CcSEcCtD
Propantheline—Dizziness—Ezetimibe—atherosclerosis	0.00509	0.00719	CcSEcCtD
Propantheline—Vomiting—Lovastatin—atherosclerosis	0.00499	0.00705	CcSEcCtD
Propantheline—Hypersensitivity—Niacin—atherosclerosis	0.00496	0.00702	CcSEcCtD
Propantheline—Rash—Lovastatin—atherosclerosis	0.00495	0.00699	CcSEcCtD
Propantheline—Dermatitis—Lovastatin—atherosclerosis	0.00494	0.00699	CcSEcCtD
Propantheline—Headache—Lovastatin—atherosclerosis	0.00491	0.00695	CcSEcCtD
Propantheline—Vomiting—Ezetimibe—atherosclerosis	0.00489	0.00692	CcSEcCtD
Propantheline—Hypersensitivity—Pravastatin—atherosclerosis	0.00489	0.00691	CcSEcCtD
Propantheline—Dizziness—Simvastatin—atherosclerosis	0.00485	0.00686	CcSEcCtD
Propantheline—Rash—Ezetimibe—atherosclerosis	0.00485	0.00686	CcSEcCtD
Propantheline—Dermatitis—Ezetimibe—atherosclerosis	0.00485	0.00685	CcSEcCtD
Propantheline—Asthenia—Niacin—atherosclerosis	0.00483	0.00683	CcSEcCtD
Propantheline—Headache—Ezetimibe—atherosclerosis	0.00482	0.00681	CcSEcCtD
Propantheline—Asthenia—Pravastatin—atherosclerosis	0.00476	0.00673	CcSEcCtD
Propantheline—Vomiting—Simvastatin—atherosclerosis	0.00466	0.0066	CcSEcCtD
Propantheline—Nausea—Lovastatin—atherosclerosis	0.00466	0.00659	CcSEcCtD
Propantheline—Rash—Simvastatin—atherosclerosis	0.00463	0.00654	CcSEcCtD
Propantheline—Dermatitis—Simvastatin—atherosclerosis	0.00462	0.00653	CcSEcCtD
Propantheline—Headache—Simvastatin—atherosclerosis	0.0046	0.0065	CcSEcCtD
Propantheline—Nausea—Ezetimibe—atherosclerosis	0.00457	0.00646	CcSEcCtD
Propantheline—Dizziness—Niacin—atherosclerosis	0.00445	0.0063	CcSEcCtD
Propantheline—Dizziness—Pravastatin—atherosclerosis	0.00439	0.0062	CcSEcCtD
Propantheline—Nausea—Simvastatin—atherosclerosis	0.00436	0.00616	CcSEcCtD
Propantheline—Vomiting—Niacin—atherosclerosis	0.00428	0.00606	CcSEcCtD
Propantheline—Rash—Niacin—atherosclerosis	0.00425	0.00601	CcSEcCtD
Propantheline—Dermatitis—Niacin—atherosclerosis	0.00424	0.006	CcSEcCtD
Propantheline—Headache—Niacin—atherosclerosis	0.00422	0.00597	CcSEcCtD
Propantheline—Vomiting—Pravastatin—atherosclerosis	0.00422	0.00596	CcSEcCtD
Propantheline—Rash—Pravastatin—atherosclerosis	0.00418	0.00591	CcSEcCtD
Propantheline—Dermatitis—Pravastatin—atherosclerosis	0.00418	0.00591	CcSEcCtD
Propantheline—Headache—Pravastatin—atherosclerosis	0.00416	0.00588	CcSEcCtD
Propantheline—Nausea—Niacin—atherosclerosis	0.004	0.00566	CcSEcCtD
Propantheline—Nausea—Pravastatin—atherosclerosis	0.00394	0.00557	CcSEcCtD
Propantheline—CHRM3—Signaling by GPCR—AGTR1—atherosclerosis	0.000225	0.000769	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—KNG1—atherosclerosis	0.000224	0.000766	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—UTS2—atherosclerosis	0.000223	0.000764	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AGTR1—atherosclerosis	0.000223	0.000762	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CX3CR1—atherosclerosis	0.000217	0.000742	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CASR—atherosclerosis	0.000217	0.000742	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CX3CR1—atherosclerosis	0.000216	0.000739	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CASR—atherosclerosis	0.000216	0.000739	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—NAMPT—atherosclerosis	0.000216	0.000737	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—LIPC—atherosclerosis	0.000214	0.000733	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CX3CR1—atherosclerosis	0.000214	0.000732	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CASR—atherosclerosis	0.000214	0.000732	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOC3—atherosclerosis	0.000213	0.000728	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CX3CL1—atherosclerosis	0.000213	0.000727	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CX3CL1—atherosclerosis	0.000212	0.000725	CbGpPWpGaD
Propantheline—CHRM1—Circadian rythm related genes—IL6—atherosclerosis	0.000212	0.000724	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—LDLR—atherosclerosis	0.000212	0.000724	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—EDN1—atherosclerosis	0.000211	0.00072	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—EDN1—atherosclerosis	0.00021	0.000718	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CX3CL1—atherosclerosis	0.00021	0.000718	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—CCL5—atherosclerosis	0.000209	0.000715	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—CCL5—atherosclerosis	0.000209	0.000713	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—EDN1—atherosclerosis	0.000208	0.000711	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CETP—atherosclerosis	0.000207	0.000707	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—CCL5—atherosclerosis	0.000207	0.000706	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CNR2—atherosclerosis	0.000202	0.000689	CbGpPWpGaD
Propantheline—CHRM1—GPCR ligand binding—CXCL8—atherosclerosis	0.000202	0.000689	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—MMP3—atherosclerosis	0.000201	0.000688	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CNR2—atherosclerosis	0.000201	0.000687	CbGpPWpGaD
Propantheline—CHRM3—GPCR ligand binding—CXCL8—atherosclerosis	0.000201	0.000687	CbGpPWpGaD
Propantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000201	0.000686	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—MMP3—atherosclerosis	0.000201	0.000686	CbGpPWpGaD
Propantheline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.0002	0.000684	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CNR2—atherosclerosis	0.000199	0.000681	CbGpPWpGaD
Propantheline—CHRM2—GPCR ligand binding—CXCL8—atherosclerosis	0.000199	0.00068	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PRKCG—atherosclerosis	0.000199	0.00068	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—MMP3—atherosclerosis	0.000199	0.000679	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PRKCG—atherosclerosis	0.000198	0.000677	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—SCARB1—atherosclerosis	0.000198	0.000677	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000196	0.000671	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—EDN1—atherosclerosis	0.000191	0.000654	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—EDN1—atherosclerosis	0.000191	0.000652	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CCL5—atherosclerosis	0.00019	0.000649	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CCL5—atherosclerosis	0.000189	0.000647	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—EDN1—atherosclerosis	0.000189	0.000646	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CCL5—atherosclerosis	0.000188	0.000641	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—HMGCR—atherosclerosis	0.000187	0.000639	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000181	0.000617	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PRKCG—atherosclerosis	0.00018	0.000615	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—VWF—atherosclerosis	0.00018	0.000614	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—VWF—atherosclerosis	0.000179	0.000613	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOC3—atherosclerosis	0.000179	0.000611	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PRKCG—atherosclerosis	0.000178	0.000609	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOC3—atherosclerosis	0.000178	0.000609	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—LDLR—atherosclerosis	0.000178	0.000607	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—VWF—atherosclerosis	0.000178	0.000607	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—LDLR—atherosclerosis	0.000177	0.000605	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOC3—atherosclerosis	0.000176	0.000603	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—LDLR—atherosclerosis	0.000175	0.000599	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000175	0.000598	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AGT—atherosclerosis	0.000174	0.000596	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCL3—atherosclerosis	0.000174	0.000593	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCL3—atherosclerosis	0.000173	0.000591	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AGT—atherosclerosis	0.000173	0.00059	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCL3—atherosclerosis	0.000171	0.000585	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ABCA1—atherosclerosis	0.000167	0.00057	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NCF1—atherosclerosis	0.000166	0.000568	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NCF1—atherosclerosis	0.000166	0.000566	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NCF1—atherosclerosis	0.000164	0.00056	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—F2—atherosclerosis	0.000162	0.000553	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—F2—atherosclerosis	0.000161	0.000551	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—F2—atherosclerosis	0.00016	0.000545	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AGT—atherosclerosis	0.000159	0.000543	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AGT—atherosclerosis	0.000158	0.000541	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	0.000157	0.000536	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCR2—atherosclerosis	0.000157	0.000536	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AGT—atherosclerosis	0.000157	0.000536	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EDNRA—atherosclerosis	0.000156	0.000534	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCR2—atherosclerosis	0.000156	0.000534	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CYBA—atherosclerosis	0.000156	0.000534	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CYBA—atherosclerosis	0.000156	0.000532	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EDNRA—atherosclerosis	0.000155	0.000529	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCR2—atherosclerosis	0.000155	0.000529	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000155	0.000529	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000154	0.000527	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CYBA—atherosclerosis	0.000154	0.000527	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—GHRL—atherosclerosis	0.000153	0.000522	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PARP1—atherosclerosis	0.000153	0.000522	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PLAT—atherosclerosis	0.000153	0.000522	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000153	0.000522	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PLAT—atherosclerosis	0.000152	0.000521	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—GHRL—atherosclerosis	0.000152	0.000521	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PARP1—atherosclerosis	0.000152	0.000521	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PARP1—atherosclerosis	0.000151	0.000516	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PLAT—atherosclerosis	0.000151	0.000516	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GHRL—atherosclerosis	0.000151	0.000516	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—F2—atherosclerosis	0.000147	0.000502	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—F2—atherosclerosis	0.000146	0.0005	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—F2—atherosclerosis	0.000145	0.000495	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—HMOX1—atherosclerosis	0.000143	0.000489	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000141	0.00048	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	0.00014	0.000479	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000139	0.000474	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOB—atherosclerosis	0.000137	0.000468	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—KNG1—atherosclerosis	0.000134	0.000459	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—KNG1—atherosclerosis	0.000134	0.000457	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	0.000133	0.000456	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GSTM1—atherosclerosis	0.000133	0.000455	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	0.000133	0.000454	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—KNG1—atherosclerosis	0.000133	0.000453	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	0.000132	0.00045	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	0.000131	0.000447	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—LPL—atherosclerosis	0.000131	0.000447	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	0.00013	0.000446	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PLG—atherosclerosis	0.00013	0.000444	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PLG—atherosclerosis	0.00013	0.000443	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	0.000129	0.000441	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PLG—atherosclerosis	0.000128	0.000439	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GPX1—atherosclerosis	0.000128	0.000436	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CD36—atherosclerosis	0.000124	0.000425	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	0.000123	0.000421	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	0.000123	0.000419	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	0.000122	0.000415	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MMP3—atherosclerosis	0.000119	0.000406	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MMP3—atherosclerosis	0.000119	0.000405	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IGF2—atherosclerosis	0.000118	0.000405	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IGF2—atherosclerosis	0.000118	0.000403	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—MTHFR—atherosclerosis	0.000118	0.000402	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MMP3—atherosclerosis	0.000117	0.000401	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IGF2—atherosclerosis	0.000117	0.000399	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPARA—atherosclerosis	0.000116	0.000395	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOB—atherosclerosis	0.000115	0.000393	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOB—atherosclerosis	0.000115	0.000391	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000114	0.000389	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	0.000114	0.000388	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOB—atherosclerosis	0.000113	0.000388	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EDN1—atherosclerosis	0.000113	0.000386	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EDN1—atherosclerosis	0.000113	0.000385	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000113	0.000384	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCL5—atherosclerosis	0.000112	0.000383	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AGT—atherosclerosis	0.000112	0.000382	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCL5—atherosclerosis	0.000112	0.000382	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EDN1—atherosclerosis	0.000112	0.000382	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCL5—atherosclerosis	0.000111	0.000379	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—LPL—atherosclerosis	0.00011	0.000375	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOE—atherosclerosis	0.00011	0.000375	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—LPL—atherosclerosis	0.000109	0.000374	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CAV1—atherosclerosis	0.000109	0.000371	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOA1—atherosclerosis	0.000108	0.00037	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—LPL—atherosclerosis	0.000108	0.00037	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	0.000107	0.000365	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	0.000106	0.000363	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	0.000105	0.00036	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SPP1—atherosclerosis	0.000104	0.000355	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SPP1—atherosclerosis	0.000104	0.000354	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	0.000103	0.000354	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	0.000103	0.000352	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SPP1—atherosclerosis	0.000103	0.000351	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	0.000102	0.000349	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3CG—atherosclerosis	9.9e-05	0.000338	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	9.62e-05	0.000329	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	9.59e-05	0.000328	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPARG—atherosclerosis	9.55e-05	0.000326	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	9.49e-05	0.000324	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AGT—atherosclerosis	9.39e-05	0.000321	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—INS—atherosclerosis	9.37e-05	0.00032	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AGT—atherosclerosis	9.36e-05	0.00032	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AGT—atherosclerosis	9.27e-05	0.000317	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOE—atherosclerosis	9.2e-05	0.000314	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—LEP—atherosclerosis	9.2e-05	0.000314	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOE—atherosclerosis	9.17e-05	0.000313	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—LEP—atherosclerosis	9.17e-05	0.000313	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CAV1—atherosclerosis	9.12e-05	0.000311	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOA1—atherosclerosis	9.09e-05	0.000311	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CAV1—atherosclerosis	9.09e-05	0.00031	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—LEP—atherosclerosis	9.08e-05	0.00031	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOE—atherosclerosis	9.08e-05	0.00031	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOA1—atherosclerosis	9.07e-05	0.00031	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CAV1—atherosclerosis	9e-05	0.000307	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOA1—atherosclerosis	8.98e-05	0.000307	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ESR1—atherosclerosis	8.78e-05	0.0003	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ESR1—atherosclerosis	8.76e-05	0.000299	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—F2—atherosclerosis	8.68e-05	0.000296	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ESR1—atherosclerosis	8.67e-05	0.000296	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—F2—atherosclerosis	8.65e-05	0.000295	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ALB—atherosclerosis	8.59e-05	0.000293	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—F2—atherosclerosis	8.56e-05	0.000293	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	8.3e-05	0.000284	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	8.28e-05	0.000283	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—NOS3—atherosclerosis	8.22e-05	0.000281	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	8.2e-05	0.00028	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	7.95e-05	0.000272	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	7.93e-05	0.000271	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—INS—atherosclerosis	7.86e-05	0.000269	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	7.85e-05	0.000268	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—INS—atherosclerosis	7.83e-05	0.000268	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—INS—atherosclerosis	7.76e-05	0.000265	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCL2—atherosclerosis	7.73e-05	0.000264	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCL2—atherosclerosis	7.71e-05	0.000263	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCL2—atherosclerosis	7.63e-05	0.000261	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IGF1—atherosclerosis	7.6e-05	0.00026	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IGF1—atherosclerosis	7.58e-05	0.000259	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTGS2—atherosclerosis	7.52e-05	0.000257	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IGF1—atherosclerosis	7.5e-05	0.000256	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	7.22e-05	0.000247	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	7.2e-05	0.000246	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	7.13e-05	0.000243	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NOS3—atherosclerosis	6.89e-05	0.000235	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NOS3—atherosclerosis	6.87e-05	0.000235	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NOS3—atherosclerosis	6.8e-05	0.000232	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	6.11e-05	0.000209	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	6.09e-05	0.000208	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	6.04e-05	0.000206	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	5.91e-05	0.000202	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	5.89e-05	0.000201	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	5.83e-05	0.000199	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL6—atherosclerosis	5.81e-05	0.000199	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL6—atherosclerosis	5.8e-05	0.000198	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL6—atherosclerosis	5.74e-05	0.000196	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MMP9—atherosclerosis	5.53e-05	0.000189	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MMP9—atherosclerosis	5.51e-05	0.000188	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	5.47e-05	0.000187	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MMP9—atherosclerosis	5.46e-05	0.000186	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	5.45e-05	0.000186	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	5.4e-05	0.000185	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	5.38e-05	0.000184	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	5.36e-05	0.000183	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	5.36e-05	0.000183	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	5.35e-05	0.000183	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	5.31e-05	0.000181	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	5.29e-05	0.000181	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	4.97e-05	0.00017	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	4.95e-05	0.000169	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—STAT3—atherosclerosis	4.92e-05	0.000168	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	4.9e-05	0.000167	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—STAT3—atherosclerosis	4.9e-05	0.000167	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—STAT3—atherosclerosis	4.85e-05	0.000166	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	4.7e-05	0.00016	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	4.68e-05	0.00016	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	4.64e-05	0.000158	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	4.56e-05	0.000156	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	4.54e-05	0.000155	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	4.5e-05	0.000154	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AKT1—atherosclerosis	3.78e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL6—atherosclerosis	3.43e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL6—atherosclerosis	3.42e-05	0.000117	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL6—atherosclerosis	3.39e-05	0.000116	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT1—atherosclerosis	3.17e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT1—atherosclerosis	3.16e-05	0.000108	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT1—atherosclerosis	3.13e-05	0.000107	CbGpPWpGaD
